Evaluation of a physician-focused educational intervention on medicaid children with asthma

Annals of Pharmacotherapy

Volumn 38, Issue 6, 2004, Pages 961-966

  Lee, Euni ^a   McNally, Diane L ^b   Zuckerman, Ilene H ^b  

^a HOWARD UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Asthma; Children; Drug utilization review; Medicaid

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE MODIFIER; MAST CELL STABILIZER; SALMETEROL; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE;

ADOLESCENT; ADULT; AGE; ANAMNESIS; ARTICLE; ASTHMA; BOOK; CHILD; CLINICAL PRACTICE; CONSULTATION; CONTROLLED STUDY; DISEASE CONTROL; DRUG USE; EMERGENCY WARD; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MEDICAID; MEDICAL FEE; OUTCOMES RESEARCH; PATIENT EDUCATION; PHYSICIAN; POSTAL MAIL; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS;

ADOLESCENT; ALBUTEROL; ASTHMA; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; EDUCATION, MEDICAL, CONTINUING; FEMALE; HUMANS; MALE; MEDICAID; NEBULIZERS AND VAPORIZERS; PENNSYLVANIA; PRACTICE GUIDELINES; PROGRAM EVALUATION; RECEPTORS, ADRENERGIC, BETA-2;

EID: 2442673031     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D515     Document Type: Article

References (20)

1. American Lung Association. Asthma in children fact sheet. www.lungusa.org/asthma/ascpedfac99.html (accessed 2002 Sep 24).
2. Asthma hospitalization October 1996-September 1997. Pennsylvania Health Care Cost Containment Council. Reporting number 98-06/01-03. Harrisburg, PA, 1998.
3. National Asthma Education and Prevention Program. Expert Panel report: guidelines for the diagnosis and management of asthma. No. 91-3642. Bethesda, MD: National Institutes of Health, 1991.
4. National Asthma Education and Prevention Program. Expert Panel report II: guidelines for the diagnosis and management of asthma. No. 97-4051. Bethesda, MD: National Institutes of Health, 1997.
5. National Asthma Education and Prevention Program. Expert Panel report: guidelines for the diagnosis and management of asthma update on selected topics-2002. No. 02-5075. Bethesda, MD: National Institutes of Health, 2002.
6. Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992;326:501-6.
7. Yeung M, O'Connor SA, Parry DT, Cochrane GM. Compliance with prescribed drug therapy in asthma. Respir Med 1994;88:31-5.
8. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996;98:1051-7.
9. Halterman JS, Aligne CA, Auinger P, McBride JT, Szilagyi PG. Inadequate therapy for asthma among children in the United States. Pediatrics 2000;105:272-6.
10. Yuksel N, Ginther S, Man P, Tsuyuki R. Underuse of inhaled corticosteroids in adults with asthma. Pharmacotherapy 2000;20:387-93.
11. Kemp JP. Guideline update: where do the new therapies fit in the management of asthma? NHLBI and WHO Global Initiative for Asthma. Drugs 2000;59:23-8, 43-5.
12. Spector S. Noncompliance with asthma therapy - are there solutions? J Asthma 2000;37:381-8.
13. Kelly HW. Asthma pharmacotherapy: current practices and outlook. Pharmacotherapy 1997;17(1 pt 2):13S-21S.
14. Ducharme FM. Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence. BMJ 2003;326:621-5.
15. Rascati KL, Okano G, Burch C. Evaluation of physician intervention letters. Med Care 1996;34:760-6.
16. Smith DH, Christensen DB, Stergachis A, Holmes G. A randomized controlled trial of a drug use review intervention for sedative hypnotic medication. Med Care 1998;36:1013-21.
17. Sleath B, Collins T, Kelly HW, McCament-Mann L, Lien T. Effect of including both physicians and pharmacists in an asthma drug-use review intervention. Am J Health Syst Pharm 1997;54:2197-200.
18. Collins TM, Mott DA, Bigelow WE, Zimmerman DR. A controlled letter intervention to change prescribing behavior: results of a dual-targeted approach. Health Serv Res 1997;32:471-89.
19. Schaffner W, Ray WA, Federspiel CF, Miller WO. Improving antibiotic prescribing in office practice. JAMA 1983;250:1728-32.
20. Lau HS, de Boer A, Beuning K, Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 1997;50:619-25.